What is LOPJLB’s current signal on IRWD?

LOPJLB’s latest quantitative signal on Ironwood Pharmaceuticals, Inc. (IRWD) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is IRWD in?

Ironwood Pharmaceuticals, Inc. (IRWD) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Ironwood Pharmaceuticals, Inc. (IRWD)

COMPARE

Healthcare · Drug Manufacturers - Specialty & Generic · NASDAQ · US

$3.82-1.29%Close

SELLRECOVERY · day 2

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONEBEST

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $629M
Beta: 0.22
P/E (TTM): 4.56

Short % float: 9.81%
Days to cover: 6.2
SI change: -16.9%

1W: +4.95%
1M: -3.78%

vs SPY 1W: +3.78%
vs SPY 1M: -6.77%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C)…

Employees: 100
Headquarters: US
Founded: 2010
Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares out: 164.6M
Float: 96.4%

ironwoodpharma.com ↗

Key executives

Thomas A. McCourt — Chief Executive Officer & Director

Tammi Gaskins — Senior Vice President & Chief Commercial Officer.

Michael Shetzline — Chief Medical Officer, Senior Vice President and Head of Research & Drug Development

SEC filings

EDGAR · CIK 14468470 · IRWD

Analyst consensus

Hold

Bullish1136.7%

Neutral1653.3%

Bearish310.0%

L $1.00Avg $6.68H $18.00

Target$6.68+74.87%

Last$3.82

FAQ

What is LOPJLB’s current signal on IRWD?: LOPJLB’s latest quantitative signal on Ironwood Pharmaceuticals, Inc. (IRWD) is SELL in a RECOVERY regime. Signals are updated daily.
What market regime is IRWD in?: Ironwood Pharmaceuticals, Inc. (IRWD) is currently classified in the RECOVERY HMM market regime on LOPJLB.
What does Ironwood Pharmaceuticals, Inc. (IRWD) do?: Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or…

Key stats

Industry peers

Prediction markets

Company news

FAQ